高血脂症治療藥
藥物
|
↓LDL
|
↑HDL
|
↓TG
|
TC
|
忍受性
|
副作用
|
Statins
|
20-60%
|
5-10%
|
10-25%
|
15-30%
|
Good
|
↑ALT (0.5-3%) (dose-dependent)
Myalgia <10%, myositis 0.5%, rhabdo < 0.1%
|
Ezetimibe
|
15-20%
|
-
|
-
|
?
|
Good
|
|
Fibrate
|
5-15%
(↑LDL ?)
|
5-15%
|
35-50%
|
15%
|
Good
|
Myopathy risk↑with
statin.
Dyspepsia, 膽結石
|
Niacin*
|
10-25%
|
~30%
|
40%
|
25%
|
Poor – reasonable
|
NO clinical benefit (NEJM 2011;365:2255; THRIVE)
|
Resin
|
20%
|
3-5%
|
? ↑
|
20%
|
Poor
|
Bloating, 結合他藥
|
Ω-3 FA
|
↑5%
|
3%
|
25-30%
|
|
|
Dyspepsia, 腹瀉
|
Statins
|
HMG-CoA Reductase inhibitors
|
DOSE
|
標準劑量 QD
|
↓LDL
|
|
Rosuvastatin
|
Crestor (10)
|
0.5-2#
|
0.5-2# (max 40/d)
CCr <30: 0.5-1#qd
|
39-55%
|
ALT (0.5-2%), 週邊神經炎, myopathy
|
Atorvastatin
|
Lipitor (10, 40)
|
10-20-40 (max 80/d)
|
39-50%
|
同上
|
|
Pitavastatin
|
Livalo (2)
|
0.5-2#
|
38-49%
|
C/I: 急性肝衰竭, 末期LC
|
|
Simvastatin
|
Vytorin (simva (20)-ezetimibe (10)
|
20-40mg (0.5-1-2#)
|
35-40%
|
ALT, myopathy, GI
|
|
Fluvastatin
|
Lescol XL (80)
|
0.5-1#
|
25-35%
|
C/I: 同上
TG: ↓19%
|
|
Lovastatin
|
|
|
40mg /d
|
31%
|
|
Combo
|
|
|
|
|
Ezetinibe (10)-simvastatin (20)
|
Vytorin
|
|
|
|
Fibrate
|
PPARα activator
|
|
|
|
Fenofibrate
|
Fenolip (200/cap)
|
1# qd
|
|
[副]:週邊神經炎, myopathy,
rhabdo
-與TZD併用, may↓HDL
-may↑LDL, esp.,
in TG很高pt (due to improve VLDL to LDL轉化)
|
沒有留言:
張貼留言